Liu Yong, Zhang Gu, Qian Jun, Zhu Yu-ping, Ju Hai-xing, Feng Hai-yang, Zhu Hui-neng, Li De-chuan
Department of Colorectal Cancer, Zhejiang Cancer Hospital, Hangzhou, China.
Zhonghua Wai Ke Za Zhi. 2012 Oct;50(10):914-7.
To discuss the mechanism of rectal cancer apoptosis induced by preoperative chemoradiotherapy and evaluate its effect by detection of apoptosis related proteins in locally advanced colorectal cancer patients who had received preoperative chemoradiation.
To detect Bcl-XL and Bax expression in rectal cancer before and after chemoradiotherapy by EnVision method, combined with patients clinical and pathological index, statistically analysis and evaluation their relationship and clinical significance.
Patients with or without tumor shrinkage after preoperative chemoradiotherapy was 13 cases and 21 cases. While the positive rate of Bcl-XL in rectal cancer before and after chemoradiotherapy were 58.8% (20/34) and 52.9% (18/34), respectively. There were significant difference between Bcl-XL change before and after chemoradiation with tumor size, tumor cells shrinkage and operation pattern. The positive rate of Bax in rectal cancer before and after chemoradiotherapy were 32.4% (11/34) and 44.1% (15/34), respectively. There were no significant difference between Bax change before and after chemoradiotherapy with tumor cells shrinkage. There were statistically significant difference between Bax ratio (χ(2) = 9.607, P = 0.048) before and after chemoradiation while there were no significant difference between Bcl-XL/Bax ratio before and after chemoradiation with tumor shrinkage. According to layered analysis with preoperative therapy, there were statistically significant difference (χ(2) = 13.964, P = 0.007) between Bcl-XL change with operation pattern while the same of significant difference between Bax change with tumor infiltration and tumor shrinkage (χ(2) = 10.806 and 10.455, both P < 0.05).
Preoperative chemoradiation can influence rectal cancer cell's apoptosis and treatment effect by changing Bcl-XL and Bax expression. Bcl-XL downregulation and Bax upregulation have shown important function in colorectal cancer cell apoptosis which induced by preoperative chemoradiation, it can also improve the effection of chemoradiation in rectal cancer.
探讨术前放化疗诱导直肠癌细胞凋亡的机制,并通过检测接受术前放化疗的局部进展期结直肠癌患者凋亡相关蛋白来评估其疗效。
采用EnVision法检测直肠癌患者放化疗前后Bcl-XL和Bax的表达,结合患者的临床及病理指标,统计分析并评价它们之间的关系及临床意义。
术前放化疗后肿瘤缩小和未缩小的患者分别为13例和21例。直肠癌放化疗前后Bcl-XL的阳性率分别为58.8%(20/34)和52.9%(18/34)。放化疗前后Bcl-XL的变化与肿瘤大小、肿瘤细胞缩小及手术方式之间存在显著差异。直肠癌放化疗前后Bax的阳性率分别为32.4%(11/34)和44.1%(15/34)。放化疗前后Bax的变化与肿瘤细胞缩小之间无显著差异。放化疗前后Bax比值(χ(2)=9.607,P=0.048)有统计学差异,而放化疗前后Bcl-XL/Bax比值与肿瘤缩小之间无显著差异。根据术前治疗进行分层分析,Bcl-XL变化与手术方式之间存在统计学差异(χ(2)=13.964,P=0.007),而Bax变化与肿瘤浸润及肿瘤缩小之间也存在显著差异(χ(2)=10.806和10.455,P均<0.05)。
术前放化疗可通过改变Bcl-XL和Bax的表达影响直肠癌细胞的凋亡及治疗效果。Bcl-XL下调和Bax上调在术前放化疗诱导的结直肠癌细胞凋亡中发挥重要作用,还可提高直肠癌放化疗的疗效。